user avatar
Sally Church
@MaverickNY
Scientist, oncology geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
Earthling
Joined February 2008
Posts
  • Pinned
    user avatar
    Keeping a beady eye on the data. Time to apply the Feuerstein-Ratain rule to a clinical readout from #ASCO26 – a specific use case with a stark reminder: tinyurl.com/mr2fbua2
  • user avatar
  • user avatar
    This is what happens when you have scientists as leaders... they understand numbers and facts...
    It takes one minute listening to Merkel to understand why Germany has succeeded so far in controlling covid-19 where so many others failed
    00:00
    Benjamin Alvarez
  • user avatar
    It took a while @RogueNASA but so worth the wait! #resistance
  • user avatar
    Given the interest at #ASH23 in a German study on CD19 CAR-T cells in autoimmune diseases such as systemic lupus erythematosus (SLE), a potentially life threatening condition – what can we learn from prior data? A short thread 🧵...
  • user avatar
    There are no words to describe the sadness and utter desolation one feels when a dear friend of 30 years suddenly passes. Gone far too young, may he rest in peace. I shall miss his exuberant spirit greatly.
  • user avatar
    I'm delighted to say we hit our 5-year anniversary this week for BSB as a specialist oncology paid subscription service... many thought we'd last 6 mon - here we still are, going from strength to strength! Thanks to all our supporters and fans.
  • user avatar
    Ok here's my notes written during AACR predicting $BMY fail in CM026 1L NSCLC. Probably should have written it up
  • user avatar
    Nice review from Jim Allison and colleagues on "Fundamental mechanisms of immune checkpoint blockade therapy" - explaining diffs in targeting PD-1 and CTLA4: cancerdiscovery.aacrjournals.org/content/early/…
  • user avatar
    There is a huge need to develop immunotherapies to enhance T cell responses against "immunologically 'cold' tumours" with low T cell infiltration and neoantigen burden. Despite numerous company efforts, there have been few successes to report...
  • user avatar
    These pembro vs placebo curves in stage III melanoma from Prof Eggermont are a thing of beauty - great news for patients! #aacr18
  • user avatar
    Whoa 3 hours post vaccine waiting for the next #aacr21 session and light headed with tingling hands, headache and chills. My T cells are busy doing their job! 🙏
  • user avatar
    This has to be one of the most idiotic, rude, and ill advised tweets I’ve seen in 2020 given the sheer cultural diversity & productivity of cancer research labs in my stream every damn day...
    Most third-world migrants can not assimilate into civil societies. Prove me wrong.
  • user avatar
    Hit a big milestone today - 10K steps and 4.5 miles - first tine since busting my knee 2 years ago!